Private Advisory Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-121,295
| Closed | -$4.67M | – | 205 |
|
|
2024
Q2 | $4.67M | Buy |
121,295
+11,457
| +10% | +$441K | 0.61% | 45 |
|
|
2024
Q1 | $4.71M | Buy |
109,838
+63,068
| +135% | +$2.7M | 0.67% | 45 |
|
|
2023
Q4 | $1.73M | Buy |
46,770
+791
| +2% | +$29.3K | 0.3% | 79 |
|
|
2023
Q3 | $1.67M | Buy |
45,979
+10,004
| +28% | +$363K | 0.33% | 77 |
|
|
2023
Q2 | $1.28M | Sell |
35,975
-139,256
| -79% | -$4.96M | 0.25% | 91 |
|
|
2023
Q1 | $6.23M | Sell |
175,231
-35,973
| -17% | -$1.28M | 1.33% | 23 |
|
|
2022
Q4 | $7.42M | Sell |
211,204
-10,118
| -5% | -$356K | 1.62% | 18 |
|
|
2022
Q3 | $6.51M | Buy |
221,322
+128,059
| +137% | +$3.77M | 1.49% | 17 |
|
|
2022
Q2 | $5.08M | Buy |
93,263
+2,887
| +3% | +$157K | 1.15% | 30 |
|
|
2022
Q1 | $4.92M | Buy |
+90,376
| New | +$4.92M | 0.96% | 29 |
|